Global Autologous Cell Therapy Market to grow at a CAGR of 23.39% during the period 2017 - 2021; Finds New Report

Report forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, one of the major drivers for this market is increasing demand for effective drugs for cardiac and degenerative disorders. There has been an increased demand for providing effective drugs for cardiac and degenerative disorders globally. Prior to the advent of autologous cell therapies, there was no effective drug to repair a damaged heart. The discovery of possible cardiac autologous cells opened new possibilities for repairing damaged cardiac tissue caused by acute myocardial infarction or coronary artery disease.

Further, the report states that one of the major factors hindering the growth of this market is critical ethical challenges with respect to stem cell research. Over the years, there has been a continuous debate over ethical issues related to stem cell therapy. Embryonic stem cell development is continuously debated upon by scientists and policy makers. The use of human embryonic stem cells in research has always concerned decision makers and the scientific fraternity. Some of the issues include the cloning of embryonic stem cells and the destruction of embryos to create cell lines.

Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global autologous cell therapy market: Brainstorm Cell Therapeutics, Holostem Advanced Therapies, Osiris Therapeutics, Valeant, and Vericel.

Other Prominent Vendors in the market are: AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, Brainxell, Caladrius Biosciences, Cellular Biomedicine, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, and VistaGen Therapeutics.

Market driver

• Increasing demand for effective drugs for cardiac and degenerative disorders
• For a full, detailed list, view our report

Market challenge

• Critical ethical challenges with respect to stem cell research
• For a full, detailed list, view our report

Market trend

• Private funding will fuel market growth
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 92 pages “Global Autologous Cell Therapy Market 2017 - 2021” report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Pipeline Landscape, Market segmentation by application, Market Segmentation by therapy, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Please visit this link for more details: http://mrr.cm/UmW

Related Reports;

Global Lupus Therapeutic Market 2017-2021 - Visit at - http://mrr.cm/Umm

Global Patient Warming Devices Market 2017-2021 - Visit at - http://mrr.cm/Ums

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare